What does Covimex do?
COVIMEX specializes in the production and distribution of high-quality pharmaceutical products. The company focuses on meeting the evolving needs of healthcare professionals and patients through innovative solutions. With a commitment to quality and efficiency, COVIMEX aims to enhance health outcomes worldwide.
- Sectors
- Wholesalers
- Activities
- Signals
-
Reporting lossesReporting losses € -213K
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -204KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -226KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 1.14MStrong equity provides a buffer against setbacks.
Low riskLow risk 94.8%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 17.88A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Healthy social debtHealthy social debt 9.4%Social debts stay manageable relative to personnel costs.
- Shareholders
- Bmvh 99,93%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
143K
|
€
165K
|
€
158K
|
€
131K
|
|
|
€
-226K
|
€
-182K
|
€
-268K
|
€
-317K
|
|
|
€
-213K
|
€
-179K
|
€
-276K
|
€
-340K
|
|
|
€
1.14M
|
€
1.36M
|
€
1.54M
|
€
2.81M
|
|
|
94.75%
|
94.34%
|
95.01%
|
95.89%
|
|
|
€
63K
|
€
81K
|
€
81K
|
€
121K
|
|
|
€
71K
|
€
318K
|
€
979K
|
€
1.04M
|
|
|
4.00
|
5.00
|
5.00
|
5.00
|
Publications 27
All publications- Ontslagen - Benoemingen 10/10/2025
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Diversen - Ontslagen - Benoemingen - Algemene Vergadering - Boekjaar 08/10/2019
- Me. - Jaarrekening 30.09.2016, Ggk 06.03.2017, Ngl 25.04.2017 17099-0543-016 02/05/2017
- Me. - Jaarrekening 30.09.2015, Ggk 07.03.2016, Ngl 08.04.2016 16097-0253-016 14/04/2016
- Me. - Jaarrekening 30.09.2014, Ggk 02.03.2015, Ngl 31.03.2015 15084-0013-027 03/04/2015
Frequently asked questions
Answers to the most common questions about Covimex, based on official government data and the filed annual accounts.
What is the VAT number of Covimex?
The VAT number of Covimex is BE0464.765.404.
How many employees work at Covimex?
In 2025, Covimex employed 4.00 full-time equivalents (FTE).
When was Covimex established?
Covimex was founded in 07-12-1998.
What is the official address of Covimex?
The official address of Covimex is Koolskampstraat 21 Hooglede 8830.
What is the legal form of Covimex?
The juridical form of Covimex is Public limited company (NV/SA).
What is the annual revenue of Covimex?
The 2025 accounts of Covimex do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Covimex do?
COVIMEX specializes in the production and distribution of high-quality pharmaceutical products. The company focuses on meeting the evolving needs of healthcare professionals and patients through innovative solutions. With a commitment to quality and efficiency, COVIMEX aims to enhance health outcomes worldwide.
Is Covimex a reliable company?
Covimex is a registered Rechtspersoon with company number 0464.765.404 and can be verified through the official CBE database.
What is the credit limit of Covimex?
The estimated credit limit of Covimex is €55,774.
Is Covimex still active?
Covimex currently has the status "Normal situation" and is active.